Home » Newsletters » BioWorld

BioWorld

April 30, 1998

View Archived Issues

Genzyme Molecular Seeks $30M For Cancer Programs

BioCryst's BCX-34 For Psoriasis Fails Again, This Time In Phase II

Other News To Note

Ariad Placement Raises $10M For Signal Pathway Blockers

Elan Takes Over Neurex In $741M Stock Swap

Chiron's Earnings Level Off; Analysts Call For Optimism

Scottish Scientists Validate Enzyme That Detoxifies Prime Carcinogen in Cigarett